{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:35:35Z","timestamp":1775586935170,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.diabres.2007.11.019","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T07:33:33Z","timestamp":1201937613000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats"],"prefix":"10.1016","volume":"80","author":[{"given":"Takako","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirozo","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazi","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hikiami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotoshi","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2007.11.019_bib1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995\u20132025","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2007.11.019_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8227(02)00203-6","article-title":"Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats","volume":"59","author":"Hu","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2007.11.019_bib3","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/S0024-3205(03)00640-4","article-title":"Effects of Keishi-ka-jutsubu-to (traditional herbal medicine: Gui-zhi-jia-shu-fu-tang) on in vivo insulin action in streptozotocine-induced diabetic rats","volume":"73","author":"Qin","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.diabres.2007.11.019_bib4","first-page":"123","article-title":"Effect of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on insulin resistance in non-insulin dependent diabetes mellitus model mice","volume":"16","author":"Furuya","year":"1999","journal-title":"J. Tradit. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diabres.2004.11.017","article-title":"Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes","volume":"69","author":"Uno","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2007.11.019_bib6","first-page":"339","article-title":"Effects of Seishin-renshi-in on blood sugar levels of patients with non-insulin-dependent diabetes-mellitus","volume":"45","author":"Azuma","year":"1994","journal-title":"Jpn. J. Orient. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib7","first-page":"40","article-title":"Effects of Keishi-bukuryo-gan and Trapidil on the microcirculation in patients with cerebro-spinal vascular disease","volume":"9","author":"Itoh","year":"1992","journal-title":"J. Tradit. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1099-1573(199905)13:3<192::AID-PTR412>3.0.CO;2-2","article-title":"Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit","volume":"13","author":"Sekiya","year":"1999","journal-title":"Phytother. Res."},{"key":"10.1016\/j.diabres.2007.11.019_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ptr.945","article-title":"Keishi-bukuryo-gan preserves the endothelium dependent relaxation of thoracic aorta in cholesterol-fed rabbit by limiting superoxide generation","volume":"16","author":"Sekiya","year":"2002","journal-title":"Phytother. Res."},{"key":"10.1016\/j.diabres.2007.11.019_bib10","first-page":"113","article-title":"Effects of Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) on endothelial function in spontaneously hypertensive rats","volume":"18","author":"Kasahara","year":"2001","journal-title":"J. Tradit. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1078\/0944-7113-00336","article-title":"Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN\/Kob) rats","volume":"11","author":"Goto","year":"2004","journal-title":"Phytomedicine"},{"key":"10.1016\/j.diabres.2007.11.019_bib12","first-page":"156","article-title":"Amelioration of kidney damage in spontaneously diabetic WBN\/Kob rats after treatment with Keishi-bukuryo-gan","volume":"20","author":"Nakagawa","year":"2003","journal-title":"J. Tradit. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jep.2006.09.043","article-title":"Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN\/Kob rats","volume":"110","author":"Nakagawa","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.diabres.2007.11.019_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2007.11.019_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diab.41.11.1422","article-title":"Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain","volume":"41","author":"Kawano","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2007.11.019_bib16","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1016\/0168-8227(94)90269-0","article-title":"OLETF (Otsuka Long-Evans Tokushima Fatty) rats: a new NIDDM rat strain","volume":"24","author":"Kawano","year":"1994","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2007.11.019_bib17","first-page":"156","article-title":"Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals","volume":"40","author":"Ikeda","year":"1990","journal-title":"ArzneimForschung\/DrugRes."},{"key":"10.1016\/j.diabres.2007.11.019_bib18","first-page":"436","article-title":"Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats","volume":"40","author":"Sugiyama","year":"1990","journal-title":"ArzneimForschung\/DrugRes."},{"key":"10.1016\/j.diabres.2007.11.019_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/bbrc.1996.0912","article-title":"Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa\/fa) rats","volume":"223","author":"Hayakawa","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.diabres.2007.11.019_bib20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-\u03b1 in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.diabres.2007.11.019_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-5793(97)00805-3","article-title":"TNF-\u03b1 downregulates the peroxisome proliferator activated receptor-\u03b1 and the mRNAs encoding peroxisomal proteins in rat liver","volume":"412","author":"Beier","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.diabres.2007.11.019_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/00004872-200018110-00011","article-title":"The contribution of skeletal muscle tumor necrosis factor-\u03b1 to insulin resistance and hypertension in fructose-fed rats","volume":"18","author":"Togashi","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.diabres.2007.11.019_bib23","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-\u03b1","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.diabres.2007.11.019_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: Direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.diabres.2007.11.019_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI118504","article-title":"The expression of TNF-\u03b1 by human muscle. Relationship to insulin resistance","volume":"97","author":"Saghizadeh","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.diabres.2007.11.019_bib26","first-page":"E769","article-title":"Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans","volume":"255","author":"Baron","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.diabres.2007.11.019_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diab.30.12.1000","article-title":"The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterisation","volume":"30","author":"DeFronzo","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2007.11.019_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s001250050901","article-title":"Pioglitazone time-dependently reduces tumour necrosis factor-\u03b1 level in muscle and improves metabolic abnormalities in Wistar fatty rats","volume":"41","author":"Murase","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2007.11.019_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2337\/diab.36.8.897","article-title":"Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population","volume":"36","author":"Abbott","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2007.11.019_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM198903163201105","article-title":"Risk factors for coronary artery diseases in healthy persons with hyperinsulinemia and normal glucose tolerance","volume":"320","author":"Zavaroni","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/diab.46.6.983","article-title":"Skeletal muscle triglyceride levels are inversely related to insulin action","volume":"46","author":"Pan","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2007.11.019_bib32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/BF00401367","article-title":"Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia","volume":"35","author":"Widen","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2007.11.019_bib33","first-page":"161","article-title":"A study of Kampo medicines in a diabetic nephropathy model","volume":"18","author":"Nakagawa","year":"2001","journal-title":"J. Tradit. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1043-2760(03)00024-9","article-title":"The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones","volume":"14","author":"Arner","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.diabres.2007.11.019_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.diabres.2007.11.019_bib36","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.diabres.2007.11.019_bib37","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.2001.280.6.E827","article-title":"The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation","volume":"280","author":"Fruhbeck","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.diabres.2007.11.019_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","article-title":"Leptin","volume":"62","author":"Ahima","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.diabres.2007.11.019_bib39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","article-title":"Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity","volume":"2","author":"Shimomura","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.diabres.2007.11.019_bib40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822707006158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822707006158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:03:04Z","timestamp":1759172584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822707006158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0168822707006158"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2007.11.019","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2007.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}